BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 19125910)

  • 1. Use of Tris-hydroxymethyl aminomethane in severe lactic acidosis due to highly active antiretroviral therapy: a case report.
    Marfo K; Garala M; Kvetan V; Gasperino J
    J Clin Pharm Ther; 2009 Feb; 34(1):119-23. PubMed ID: 19125910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lactic acidosis type B. A life-threatening adverse effect of antiretroviral therapy].
    Justesen US; Pedersen C
    Ugeskr Laeger; 2000 Aug; 162(35):4664-5. PubMed ID: 10986895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactic acidosis and antiretroviral therapy: a case report and literature review.
    Marra A; Lewi D; Lanzoni V; Wey SB; Odashiro LN; Gomes PS; Silva E
    Braz J Infect Dis; 2000 Jun; 4(3):151-5. PubMed ID: 10934499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fanconi syndrome and lactic acidosis associated with stavudine and lamivudine therapy.
    Nelson M; Azwa A; Sokwala A; Harania RS; Stebbing J
    AIDS; 2008 Jul; 22(11):1374-6. PubMed ID: 18580619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly active antiretroviral therapy (HAART)-associated lactic acidosis: in vitro effects of combination of nucleoside analogues and protease inhibitors on mitochondrial function and lactic acid production.
    Nerurkar PV; Pearson L; Frank JE; Yanagihara R; Nerurkar VR
    Cell Mol Biol (Noisy-le-grand); 2003 Dec; 49(8):1205-11. PubMed ID: 14983988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactic acidosis secondary to nucleoside analogue antiretroviral therapy.
    Khouri S; Cushing H
    AIDS Read; 2000 Oct; 10(10):602-6. PubMed ID: 11068807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Miller Fisher variant of Guillain-Barré syndrome associated with lactic acidosis and stavudine therapy.
    Shah SS; Rodriguez T; McGowan JP
    Clin Infect Dis; 2003 May; 36(10):e131-3. PubMed ID: 12746793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A high incidence of lactic acidosis and symptomatic hyperlactatemia in women receiving highly active antiretroviral therapy in Soweto, South Africa.
    Bolhaar MG; Karstaedt AS
    Clin Infect Dis; 2007 Jul; 45(2):254-60. PubMed ID: 17578788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactic acidosis in HIV-I infected patients receiving antiretroviral therapy.
    Patel AK; Patel K; Patel J
    J Assoc Physicians India; 2004 Aug; 52():666-9. PubMed ID: 15847366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal lactic acidosis associated with highly active antiretroviral therapy in patients with advanced human immunodeficiency virus infection in Taiwan.
    Sheng WH; Hsieh SM; Lee SC; Chen MY; Wang JT; Hung CC; Chang SC
    Int J STD AIDS; 2004 Apr; 15(4):249-53. PubMed ID: 15075019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactic acidosis in an HIV-infected patient receiving highly active antiretroviral therapy.
    Patel V; Hedayati SS
    Nat Clin Pract Nephrol; 2006 Feb; 2(2):109-14; quiz 115. PubMed ID: 16932402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactic acidosis in HIV patients receiving highly active antiretroviral therapy.
    Chow YW; Leong CL; Chow HL; Hooi LS
    Med J Malaysia; 2007 Mar; 62(1):78-80. PubMed ID: 17682581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for mitochondrial toxicity: lactic acidosis as proof of concept.
    Brinkman K
    J HIV Ther; 2001 Mar; 6(1):13-6. PubMed ID: 11501196
    [No Abstract]   [Full Text] [Related]  

  • 14. Hyperlactataemia and lactic acidosis in HIV-infected patients receiving antiretroviral therapy.
    Calza L; Manfredi R; Chiodo F
    Clin Nutr; 2005 Feb; 24(1):5-15. PubMed ID: 15681097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly active antiretroviral HIV therapy-associated fatal lactic acidosis: quantitative and qualitative mitochondrial DNA lesions with mitochondrial dysfunction in multiple organs.
    Thoden J; Lebrecht D; Venhoff N; Neumann J; Müller K; Walker UA
    AIDS; 2008 May; 22(9):1093-4. PubMed ID: 18520357
    [No Abstract]   [Full Text] [Related]  

  • 16. Lactic acidosis associated with stavudine administration: a report of five cases.
    Mokrzycki MH; Harris C; May H; Laut J; Palmisano J
    Clin Infect Dis; 2000 Jan; 30(1):198-200. PubMed ID: 10619755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleoside analogue-induced fatal lactic acidosis in two HIV-infected patients in Singapore.
    Hwang SW; Leo YS
    Singapore Med J; 2001 Jun; 42(6):247-51. PubMed ID: 11547960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptomatic hyperlactatemia associated with nucleoside analogue reverse-transcriptase inhibitor use in HIV-infected patients: a report of 24 cases in a resource-limited setting (Uganda).
    Songa PM; Castelnuovo B; Mugasha EB; Ocama P; Kambugu A
    Clin Infect Dis; 2007 Aug; 45(4):514-7. PubMed ID: 17638205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactic acidosis associated with nucleoside analog therapy in an HIV-positive patient.
    Goldfarb-Rumyantzev AS; Jeyakumar A; Gumpeni R; Rubin D
    AIDS Patient Care STDS; 2000 Jul; 14(7):339-42. PubMed ID: 10935049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperlactataemia in HIV-infected patients: the role of NRTI-treatment.
    Vrouenraets SM; Treskes M; Regez RM; Troost N; Smulders YM; Weigel HM; Frissen PH; Brinkman K
    Antivir Ther; 2002 Dec; 7(4):239-44. PubMed ID: 12553477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.